Advertisement

Hematologic Disorders

Published:October 12, 2018DOI:https://doi.org/10.1016/j.anclin.2018.07.006

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Anesthesiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McLean E.
        • Cogswell M.
        • Egli I.
        • et al.
        Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993-2005.
        Public Health Nutr. 2009; 12: 444-454
        • Bruno de Benoist E.M.
        • Egli I.
        • Cogswell M.
        Worldwide prevalence of anaemia 1993-2005. WHO global database on anaemia.
        World Health Organization, Geneva (Switzerland)2008
        • Kansagra A.J.
        • Stefan M.S.
        Preoperative anemia: evaluation and treatment.
        Anesthesiol Clin. 2016; 34: 127-141
        • Yip R.
        • Johnson C.
        • Dallman P.R.
        Age-related changes in laboratory values used in the diagnosis of anemia and iron deficiency.
        Am J Clin Nutr. 1984; 39: 427-436
        • Chanarin I.
        • Metz J.
        Diagnosis of cobalamin deficiency: the old and the new.
        Br J Haematol. 1997; 97: 695-700
        • Takahashi N.
        • Kameoka J.
        • Takahashi N.
        • et al.
        Causes of macrocytic anemia among 628 patients: mean corpuscular volumes of 114 and 130 fL as critical markers for categorization.
        Int J Hematol. 2016; 104: 344-357
        • Aslinia F.
        • Mazza J.J.
        • Yale S.H.
        Megaloblastic anemia and other causes of macrocytosis.
        Clin Med Res. 2006; 4: 236-241
        • DeLoughery T.G.
        Microcytic anemia.
        N Engl J Med. 2014; 371: 1324-1331
        • Bou Monsef J.B.
        • Boettner F.
        Optimal management of perioperative anemia: current perspectives.
        Int J Clin Transfus Med. 2015; 3: 65-73
        • Camaschella C.
        Recent advances in the understanding of inherited sideroblastic anaemia.
        Br J Haematol. 2008; 143: 27-38
        • Forget B.G.
        • Bunn H.F.
        Classification of the disorders of hemoglobin.
        Cold Spring Harb Perspect Med. 2013; 3: a011684
        • Pecker L.H.
        • Schaefer B.A.
        • Luchtman-Jones L.
        Knowledge insufficient: the management of haemoglobin SC disease.
        Br J Haematol. 2017; 176: 515-526
        • Ware R.E.
        • de Montalembert M.
        • Tshilolo L.
        • et al.
        Sickle cell disease.
        Lancet. 2017; 390: 311-323
        • Khurmi N.
        • Gorlin A.
        • Misra L.
        Perioperative considerations for patients with sickle cell disease: a narrative review.
        Can J Anaesth. 2017; 64: 860-869
        • Vichinsky E.P.
        • Neumayr L.D.
        • Earles A.N.
        • et al.
        Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.
        N Engl J Med. 2000; 342: 1855-1865
        • Howard J.
        • Malfroy M.
        • Llewelyn C.
        • et al.
        The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial.
        Lancet. 2013; 381: 930-938
        • Davis B.A.
        • Allard S.
        • Qureshi A.
        • et al.
        Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion.
        Br J Haematol. 2017; 176: 192-209
        • Auerbach M.
        • Coyne D.
        • Ballard H.
        Intravenous iron: from anathema to standard of care.
        Am J Hematol. 2008; 83: 580-588
        • KDIGO clinical practice guideline for anemia in chronic kidney disease
        Kidney Int Suppl (2011). 2012; 2: 292-310
        • Palta S.
        • Saroa R.
        • Palta A.
        Overview of the coagulation system.
        Indian J Anaesth. 2014; 58: 515-523
        • Mensah P.K.
        • Gooding R.
        Surgery in patients with inherited bleeding disorders.
        Anaesthesia. 2015; 70: 112-120.e39-40
        • Blanchette V.S.
        • Key N.S.
        • Ljung L.R.
        • et al.
        Definitions in hemophilia: communication from the SSC of the ISTH.
        J Thromb Haemost. 2014; 12: 1935-1939
        • Srivastava A.
        • Brewer A.K.
        • Mauser-Bunschoten E.P.
        • et al.
        Guidelines for the management of hemophilia.
        Haemophilia. 2013; 19: e1-e47
        • Shah U.J.
        • Narayanan M.
        • Graham Smith J.
        Anaesthetic considerations in patients with inherited disorders of coagulation.
        Continuing Education in Anaesthesia Critical Care & Pain. 2015; 15: 26-31
        • Coppola A.
        • Tagliaferri A.
        • Franchini M.
        Old and new challenges in hemophilia management.
        Semin Thromb Hemost. 2013; 39: 693-696
        • Hines R.
        • Marschall K.
        Anesthesia and co-existing disease.
        Elsevier, Philadelphia2008
        • Stone M.E.
        • Mazzeffi M.
        • Derham J.
        • et al.
        Current management of von Willebrand disease and von Willebrand syndrome.
        Curr Opin Anaesthesiol. 2014; 27: 353-358
        • Khan S.
        • Dickerman J.D.
        Hereditary thrombophilia.
        Thromb J. 2006; 4: 15
        • Kalafatis M.
        • Bertina R.M.
        • Rand M.D.
        • et al.
        Characterization of the molecular defect in factor VR506Q.
        J Biol Chem. 1995; 270: 4053-4057
        • Shen L.
        • Dahlback B.
        Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa.
        J Biol Chem. 1994; 269: 18735-18738
        • Poort S.R.
        • Rosendaal F.R.
        • Reitsma P.H.
        • et al.
        A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.
        Blood. 1996; 88: 3698-3703
        • Martinelli I.
        • Mannucci P.M.
        • De Stefano V.
        • et al.
        Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
        Blood. 1998; 92: 2353-2358
        • Colucci G.
        • Tsakiris D.A.
        Thrombophilia screening: universal, selected, or neither?.
        Clin Appl Thromb Hemost. 2017; 23: 893-899
        • Lambert M.P.
        • Gernsheimer T.B.
        Clinical updates in adult immune thrombocytopenia.
        Blood. 2017; 129: 2829-2835
        • Cines D.B.
        • Bussel J.B.
        • Liebman H.A.
        • et al.
        The ITP syndrome: pathogenic and clinical diversity.
        Blood. 2009; 113: 6511-6521
        • Moulis G.
        • Palmaro A.
        • Montastruc J.L.
        • et al.
        Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
        Blood. 2014; 124: 3308-3315
        • Rodeghiero F.
        • Stasi R.
        • Gernsheimer T.
        • et al.
        Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
        Blood. 2009; 113: 2386-2393
        • Amiral J.
        • Bridey F.
        • Dreyfus M.
        • et al.
        Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.
        Thromb Haemost. 1992; 68: 95-96
        • Weismann R.E.
        • Tobin R.W.
        Arterial embolism occurring during systemic heparin therapy.
        AMA Arch Surg. 1958; 76 ([discussion: 225–7]): 219-225
        • Chong B.H.
        • Ismail F.
        The mechanism of heparin-induced platelet aggregation.
        Eur J Haematol. 1989; 43: 245-251
        • Chong B.H.
        • Fawaz I.
        • Chesterman C.N.
        • et al.
        Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets.
        Br J Haematol. 1989; 73: 235-240
        • Warkentin T.E.
        • Levine M.N.
        • Hirsh J.
        • et al.
        Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
        N Engl J Med. 1995; 332: 1330-1335
        • Bauer T.L.
        • Arepally G.
        • Konkle B.A.
        • et al.
        Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.
        Circulation. 1997; 95: 1242-1246
        • Warkentin T.E.
        • Kelton J.G.
        Temporal aspects of heparin-induced thrombocytopenia.
        N Engl J Med. 2001; 344: 1286-1292
        • Ahmed K.
        • Vohra H.A.
        • Milne A.
        • et al.
        Aortic valve replacement in a young patient with essential thrombocytosis.
        J Cardiothorac Surg. 2008; 3: 5
        • Zhu Y.
        • Jiang H.
        • Chen Z.
        • et al.
        Abdominal surgery in patients with essential thrombocythemia: a case report and systematic review of literature.
        Medicine (Baltimore). 2017; 96: e8856
        • Randi M.L.
        • Stocco F.
        • Rossi C.
        • et al.
        Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases).
        J Med. 1991; 22: 213-223
        • Kessler C.M.
        Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders.
        Semin Hematol. 2004; 41: 10-14
        • Michiels J.J.
        • Berneman Z.
        • Schroyens W.
        • et al.
        The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
        Semin Thromb Hemost. 2006; 32: 589-604
        • Edlich R.F.
        • Long 3rd, W.B.
        • Cochran A.A.
        • et al.
        Management of femoral fracture in a patient with essential thrombocythemia treated with plateletpheresis and intramedullary rod fixation, followed by hydroxyurea: a case report.
        Am J Emerg Med. 2008; 26: 636.e1-3
        • Das S.S.
        • Bose S.
        • Chatterjee S.
        • et al.
        Thrombocytapheresis: managing essential thrombocythemia in a surgical patient.
        Ann Thorac Surg. 2011; 92: e5-e6